Page 6 - Compulsory Licensing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Technology Transfer and Voluntary Licenses will help to improve vaccine supply:

Focus on technology transfer, voluntary licenses to Indian companies to address vaccine shortage: FICCI SECTIONS Share Synopsis The immediate focus has to be on connecting with the right global companies to facilitate technology transfer and voluntary licenses to Indian companies that have the capacity and capability for mass-production of COVID vaccines, FICCI said. Reuters Representative Image The government should work on war-footing to alleviate the shortage of vaccines in the country which has put the lives of healthcare service providers, essential workers at risk, the Federation of Ind...

US pharma giant Eli Lilly has issued royalty-free, non-exclusive voluntary licences to three Indian drug makers – Cipla, Sun Pharmaceuticals and Lupin – to manufacture and distribute Baricitinib, which is being used to treat Covid-19. Earlier, Gilead too had signed non-exclusive voluntary licensing agreements with Indian pharmaceutical companies to expand the production of Remdesivir, a widely used anti-Covid drug. “The voluntary licensing agreements will ensure high-quality manufacturing and accessibility of Baricitinib during this pandemic, improving the local treatment options availa...

India News: NEW DELHI: The Left parties on Saturday lashed out at the government, accusing it of wasting time in preparing for the Covid pandemic and said that if.

Scaling Up Vaccine Production: Why Compulsory Licensing Isn't The Silver Bullet That It Might Appear To Be by Ananth Krishna - May 11, 2021 07:32 AM Covid-19 vaccine doses Snapshot Even if the government were to grant other companies the licence to manufacture Covaxin, they woudn't be able to start production anytime soon. The Supreme Court on 30 April 2021, while dealing with the suo moto petition regarding the management of Covid-19 in India asked why compulsory licensing cannot be invoked under Section 92 of the Patent Act for the manufacture of vaccines. The bench asks if the Centre has...